what we do
Dedicated to the development of novel ancillary devices through strategic partnerships to enhance transcatheter treatments for valvular and other structural cardiac diseases.
Primary Services for our Partners
Development of a full array of supportive devices to enhance transcatheter and minimally invasive structural cardiac procedures.
Improve procedural safety, efficacy, and efficiency.
Minimize or reduce overall procedural cost.
Broad dissemination of appropriate and safe use of new technologies through educational programs.
Offer consultative services for cutting edge approaches for the treatment of valvular and other structural heart diseases.
Current Efforts
Under contractual agreements with:
Teleflex Incorporated for the design and development of novel transatrial-septal devices and left heart delivery systems.
Nextern Incorporated for the design and development of a temporary pacemaker lead systems.